Lawyers believe that a class action against transvaginal mesh manufacturer Johnson & Johnson could be the largest product class action in Australian legal history. An estimated 20,000 Australian women have had transvaginal mesh implants and many have reported experiencing severe side effects such as vaginal mesh erosion and scarring.
Australians are frustrated with the regulatory practices of the Therapeutic Goods Administration (TGA), as this class action against Johnson & Johnson will be the third against the manufacturer in just three years. While the U.S. Food and Drug Administration (FDA) issued a warning about transvaginal mesh to consumers in July 2011, there has still been no such warning issued by the TGA.
Transvaginal mesh has many known complications, one of the most common being vaginal mesh erosion. The 2011 FDA warning stated that users of transvaginal mesh are at risk of side effects that are not experienced by patients who undergo traditional surgery to repair pelvic organ prolapse.